iCAD, Inc. (NASDAQ: ICAD) Starts Presentation at LD Micro 2017 Invitational
iCAD (NASDAQ: ICAD) is a pharmaceutical company that delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. The company offers a comprehensive range of upgradeable computer-aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers. iCAD's Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. For more information, visit the company's website at www.icadmed.com. About NetworkNewsWire…







